治疗慢性疼痛的大麻油提取物:还有什么可以从另一个结构化的潜在队列中学到的呢?
Dorit Pud1, Suhail Aamar2, Bareket Schiff-Keren3
1Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
Pain reports
|April 29, 2024
概括
大麻油提取物在六个月内对慢性疼痛和相关症状的长期改善是适度的. 治疗通常是安全的,在这个患者队列中报告的大部分是不严重的不良事件.
科学领域:
- 疼痛管理 疼痛管理
- 大麻素治疗药物 大麻素治疗药物
- 临床研究 临床研究
背景情况:
- 治疗疼痛的医用大麻使用量正在增加,但随机对照试验的强有力的证据有限.
- 含有大麻和Δ9-四化大麻的大麻油提取物用于慢性疼痛管理.
研究的目的:
- 评估大麻油提取物在慢性疼痛患者的长期有效性和安全性.
- 在六个月的时间内评估疼痛强度,相关症状和生活质量的变化.
主要方法:
- 长期疼痛的成年以色列患者的前性,基于问卷的队列研究.
- 患者接受了个别定位的大麻油提取物六个月.
- 疼痛强度,症状和生活质量在基线和一,三,六个月后被评估.
主要成果:
- 总共有218名患者在基线被纳入,其中131人完成了六个月的随访.
- 平均每周疼痛强度在六个月内显著下降,从7.9降至6.6 (P < 0.0001).
- 24%的患者被确定为"反应者" (≥30%的疼痛减轻),在次要结果中显示出更大的改善. 副作用很常见,但大多是轻微的.
结论:
- 大麻油提取物在慢性疼痛和相关症状方面表现出适度的长期改善.
- 治疗表现出合理的安全性,单独定位,相对较低的Δ9-四大麻素和大麻的剂量.
- 需要进一步的研究来确定最终的疗效和安全性.
相关概念视频
Analgesia and Pain Management
585
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
585
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
237
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
237
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Opioid Analgesics: Synthetic and Semisynthetic Opioids
287
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Opioid Analgesics: Morphine and Other Natural Cogeners
242
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
242


